By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider activity at AbbVie Inc. has been all selling for a year now: about $18.9 million from three sellers, and zero buyers in open-market trades.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Members of Congress reported 38 trades in ABBV over the past two years (14 members). 4,209 investment managers listed ABBV in their latest 13F filings (Q2 2026); more funds bought than sold. Looking at the quarterly pattern: Last full quarter: net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
Are insiders buying or selling ABBV stock?
In the last 12 months AbbVie Inc. insiders made open-market purchases worth about $0 and sales worth about $18.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in ABBV?
The most recent open-market insider trade in ABBV was filed on 2026-08-18.
How many institutions own ABBV?
4,209 investment managers reported holding ABBV in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded ABBV?
Yes. Members of Congress reported 38 trades in ABBV over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).